AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation. (Q53223182)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

title

AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

author name string

X N Gao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

F Yan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

J Lin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

L Gao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

X L Lu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

S C Wei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

N Shen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

J X Pang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

Q Y Ning

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

Y Komeno

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

A L Deng

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

Y H Xu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

J L Shi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

Y H Li

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

D E Zhang

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

S J Liu

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

L Yu

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

publication date

2 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

1730-1740

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25727291 AND SRC:MED&resulttype=core&format=json

The 8;21 translocation in leukemogenesis

1 March 2020

cites work

1 reference

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations

21 January 2018

1 reference

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

21 January 2018

1 reference

The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice

21 January 2018

1 reference

Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts

21 January 2018

1 reference

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study

21 January 2018

1 reference

Hypoxia-inducible factors, stem cells, and cancer

21 January 2018

1 reference

HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia

21 January 2018

1 reference

Functional regulation of HIF-1α under normoxia--is there more than post-translational regulation?

21 January 2018

1 reference

IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells

21 January 2018

1 reference

Targeting HIF1α eliminates cancer stem cells in hematological malignancies.

21 January 2018

1 reference

DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.

21 January 2018

1 reference

The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia

21 January 2018

1 reference

The AML1-MTG8 Leukemic Fusion Protein Forms a Complex with a Novel Member of the MTG8(ETO/CDR) Family, MTGR1

21 January 2018

1 reference

ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex

21 January 2018

1 reference

Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.

21 January 2018

1 reference

The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity

21 January 2018

1 reference

Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.

21 January 2018

1 reference

Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia

21 January 2018

1 reference

A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis

21 January 2018

1 reference

High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia.

21 January 2018

1 reference

Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells

21 January 2018

1 reference

AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets

21 January 2018

1 reference

Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.

21 January 2018

1 reference

Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction

21 January 2018

1 reference

Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis

21 January 2018

1 reference

Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts

21 January 2018

1 reference

A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis

21 January 2018

1 reference

Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity

21 January 2018

1 reference

Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia

21 January 2018

1 reference

The role of hypoxia-induced factors in tumor progression

21 January 2018

1 reference

The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy.

21 January 2018

1 reference

HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers

21 January 2018

1 reference

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

21 January 2018

1 reference

Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway

21 January 2018

1 reference

Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs.

21 January 2018

1 reference

The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation

21 January 2018

1 reference

PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential

21 January 2018

1 reference

Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha

21 January 2018

1 reference

Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha

21 January 2018

1 reference

Multilevel regulation of HIF-1 signaling by TTP.

21 January 2018

1 reference

Hypoxia-induced methylation of a pontin chromatin remodeling factor

21 January 2018

1 reference

Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype

21 January 2018

1 reference

Induction of DNA hypomethylation by tumor hypoxia.

21 January 2018

1 reference

Hypoxia Induces Genomic DNA Demethylation through the Activation of HIF-1α and Transcriptional Upregulation of MAT2A in Hepatoma Cells

21 January 2018

1 reference

Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO

21 January 2018

1 reference

AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia

21 January 2018

1 reference

12 December 2020

Elevated HIF-1α expression of acute myelogenous leukemia stem cells in the endosteal hypoxic zone may be a cause of minimal residual disease in bone marrow after chemotherapy

1 reference

12 December 2020

Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.

1 reference

12 December 2020

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

12 December 2020

Quantification of AML1-ETO fusion transcript as a prognostic indicator in acute myeloid leukemia.

1 reference

12 December 2020

JAK2V617F mutations as cooperative genetic lesions in t(8;21)-positive acute myeloid leukemia

1 reference

12 December 2020